Your browser doesn't support javascript.
loading
The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease.
Higgins, Abigail Louise; Toffoli, Marco; Mullin, Stephen; Lee, Chiao-Yin; Koletsi, Sofia; Avenali, Micol; Blandini, Fabio; Schapira, Anthony Hv.
Affiliation
  • Higgins AL; Department of Clinical & Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.
  • Toffoli M; Department of Clinical & Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.
  • Mullin S; Institute of Translational and Stratified Medicine, University of Plymouth Peninsula School of Medicine, Plymouth, UK.
  • Lee CY; Department of Clinical & Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.
  • Koletsi S; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
  • Avenali M; Department of Clinical & Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.
  • Blandini F; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
  • Schapira AH; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
Neurodegener Dis Manag ; 11(6): 451-458, 2021 12.
Article in En | MEDLINE | ID: mdl-34666501
ABSTRACT
Mutations in GBA which are causative of Gaucher disease in their biallelic form, are the most common genetic risk factor for Parkinson's disease (PD). The diagnosis of PD relies upon clinically defined motor features which appear after irreversible neurodegeneration. Prodromal symptoms of PD may provide a means to predict latent pathology, years before the onset of motor features. Previous work has reported prodromal features of PD in GBA mutation carriers, however this has been insufficiently sensitive to identify those that will develop PD. The Remote Assessment of Parkinsonism Supporting Ongoing Development of Interventions in Gaucher Disease (RAPSODI GD) study assesses a large cohort of GBA mutation carriers, to aid development of procedures for earlier diagnosis of PD.
Lay abstract Changes in a gene called GBA cause a rare condition called Gaucher disease and are the most common genetic risk factor for Parkinson's disease (PD). To diagnose PD, patients must show symptoms of disordered movement which only occur after irreversible brain cell loss. Earlier symptoms may allow for the prediction of PD, years before movement symptoms occur. Previous work has reported earlier symptoms of PD occurring in people with GBA changes, however these studies have not been able to identify those at risk of developing PD. The Remote Assessment of Parkinsonism Supporting Ongoing Development of Interventions in Gaucher Disease (RAPSODI GD) study assesses a large group of people with GBA changes, to help develop a way to diagnose PD earlier.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Parkinsonian Disorders / Gaucher Disease Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Neurodegener Dis Manag Year: 2021 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Parkinsonian Disorders / Gaucher Disease Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Neurodegener Dis Manag Year: 2021 Document type: Article Affiliation country: United kingdom